South Korea · Delayed Price · Currency is KRW OPTUS Pharmaceutical Statistics
Total Valuation
KOSDAQ:131030 has a market cap or net worth of KRW 102.35 billion. The enterprise value is 69.02 billion.
| Market Cap | 102.35B |
| Enterprise Value | 69.02B |
Important Dates
The last earnings date was Friday, January 23, 2026.
| Earnings Date | Jan 23, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
KOSDAQ:131030 has 17.65 million shares outstanding. The number of shares has increased by 4.23% in one year.
| Current Share Class | 17.65M |
| Shares Outstanding | 17.65M |
| Shares Change (YoY) | +4.23% |
| Shares Change (QoQ) | +2.77% |
| Owned by Insiders (%) | 0.74% |
| Owned by Institutions (%) | 3.82% |
| Float | 9.58M |
Valuation Ratios
The trailing PE ratio is 7.28.
| PE Ratio | 7.28 |
| Forward PE | n/a |
| PS Ratio | 1.12 |
| PB Ratio | 0.58 |
| P/TBV Ratio | 0.64 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 7.69 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 5.44 |
| EV / Sales | 0.75 |
| EV / EBITDA | 4.38 |
| EV / EBIT | 6.36 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.28, with a Debt / Equity ratio of 0.01.
| Current Ratio | 3.28 |
| Quick Ratio | 2.66 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | 0.09 |
| Debt / FCF | -0.04 |
| Interest Coverage | 159.64 |
Financial Efficiency
Return on equity (ROE) is 7.91% and return on invested capital (ROIC) is 8.01%.
| Return on Equity (ROE) | 7.91% |
| Return on Assets (ROA) | 3.79% |
| Return on Invested Capital (ROIC) | 8.01% |
| Return on Capital Employed (ROCE) | 6.14% |
| Weighted Average Cost of Capital (WACC) | 3.89% |
| Revenue Per Employee | 576.26M |
| Profits Per Employee | 79.85M |
| Employee Count | 159 |
| Asset Turnover | 0.51 |
| Inventory Turnover | 2.94 |
Taxes
In the past 12 months, KOSDAQ:131030 has paid 110.81 million in taxes.
| Income Tax | 110.81M |
| Effective Tax Rate | 0.87% |
Stock Price Statistics
The stock price has decreased by -6.99% in the last 52 weeks. The beta is -0.07, so KOSDAQ:131030's price volatility has been lower than the market average.
| Beta (5Y) | -0.07 |
| 52-Week Price Change | -6.99% |
| 50-Day Moving Average | 9,099.80 |
| 200-Day Moving Average | 8,270.65 |
| Relative Strength Index (RSI) | 27.73 |
| Average Volume (20 Days) | 135,524 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, KOSDAQ:131030 had revenue of KRW 91.62 billion and earned 12.70 billion in profits. Earnings per share was 796.92.
| Revenue | 91.62B |
| Gross Profit | 50.75B |
| Operating Income | 10.86B |
| Pretax Income | 12.81B |
| Net Income | 12.70B |
| EBITDA | 15.75B |
| EBIT | 10.86B |
| Earnings Per Share (EPS) | 796.92 |
Balance Sheet
The company has 34.70 billion in cash and 1.38 billion in debt, with a net cash position of 33.33 billion or 1,888.53 per share.
| Cash & Cash Equivalents | 34.70B |
| Total Debt | 1.38B |
| Net Cash | 33.33B |
| Net Cash Per Share | 1,888.53 |
| Equity (Book Value) | 176.05B |
| Book Value Per Share | 10,509.07 |
| Working Capital | 47.93B |
Cash Flow
In the last 12 months, operating cash flow was 13.32 billion and capital expenditures -50.08 billion, giving a free cash flow of -36.77 billion.
| Operating Cash Flow | 13.32B |
| Capital Expenditures | -50.08B |
| Depreciation & Amortization | 4.89B |
| Net Borrowing | -776.00M |
| Free Cash Flow | -36.77B |
| FCF Per Share | -2,083.59 |
Margins
Gross margin is 55.39%, with operating and profit margins of 11.85% and 13.86%.
| Gross Margin | 55.39% |
| Operating Margin | 11.85% |
| Pretax Margin | 13.98% |
| Profit Margin | 13.86% |
| EBITDA Margin | 17.19% |
| EBIT Margin | 11.85% |
| FCF Margin | n/a |
Dividends & Yields
KOSDAQ:131030 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -4.23% |
| Shareholder Yield | -4.23% |
| Earnings Yield | 12.40% |
| FCF Yield | -35.92% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
KOSDAQ:131030 has an Altman Z-Score of 5.25 and a Piotroski F-Score of 5.
| Altman Z-Score | 5.25 |
| Piotroski F-Score | 5 |